EDNRA and autosomal dominant polycystic kidney disease: However, recent studies demonstrate differential effects of ETA and ETB receptors in progression of kidney disease and favor a reno-protective effect of ETA receptor antagonists [36], so studies are necessary to determine efficacy of ET-1 receptor blockers in ADPKD.